Biomarkers for Parkinsonian Disorders From CNS-Originating Extracellular Vesicles

Overview

About this study

The purpose of this study is to create biomarkers for parkinsonian disorders in CNS-originating extracellular vesicles.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Possible or Probable MSA (regardless of type).
At least one other supporting test (CSF, imaging, RT-QuIC, smell test, autonomic testing). Does not have to be uniform but at least one supporting test is required. If any additional information supporting the diagnosis is available, please add to the accompanying data.

Exclusion Criteria:

N/A

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 2/28/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Wolfgang Singer, M.D.	Open for enrollment	Contact information: Tonette Gehrking CAP (507) 284-0336 adc.research@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Wolfgang Singer, M.D.

Open for enrollment

Contact information:

Tonette Gehrking CAP

(507) 284-0336

adc.research@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials